The aims of this study are to investigate the course of work functioning, health status, and work-related factors among cancer patients during 18 months after return to work (RTW) and to examine the associations between these variables and work functioning over time.
Data were used from the 18-month longitudinal “Work Life after Cancer” (WOLICA) cohort, among 384 cancer patients who resumed work. Linear mixed models were performed to examine the different courses during 18-month follow-up. Linear regression analyses with generalized estimating equations (GEE) were used to examine the associations and interactions.
Cancer patients reported an increase of work functioning and a decrease of fatigue and depressive symptoms in the first 12 months, followed by a stable course between 12 and 18 months. Cognitive symptoms were stable during the first 18 months. Working hours increased and social support decreased during the first 6 months; both remained stable between 6 and 18 months. Fatigue, depressive, and cognitive symptoms were negatively associated with work functioning over time; working hours and supervisor social support were positively associated.
Interventions to improve cancer patients’ work functioning over time might be promising if they are aimed at reducing fatigue, depressive symptoms, cognitive symptoms, and encouraging supervisor social support.
It is important to monitor cancer patients not only in the period directly after RTW but up to 18 months after RTW, allowing for timely interventions when needed.
Parry C, Kent EE, Mariotto AB, Alfano CM, Rowland JH. Cancer survivors: a booming population. Cancer Epidemiol Biomark Prev. 2011;20(10):1996–2005. https://doi.org/10.1158/1055-9965.EPI-11-0729. CrossRef
Ries LAG, Melberg D, Krapcho M, et al. SEER cancer statistics review, 1975-2004. Bethesda: National Cancer Institute; 2007.
Mehnert A. Employment and work-related issues in cancer survivors. Crit Rev Oncol. 2011;77:109–30. CrossRef
Moore HCF. An overview of chemotherapy-related cognitive dysfunction, or 'chemobrain. Oncology (Williston Park). 2014;28:797–804.
Kaiser J, Bledowski C, Dietrich J. Neural correlates of chemotherapy-related cognitive impairment. Cortex. 2014;54:33–50. https://doi.org/10.1016/j.cortex.2014.01.010. CrossRefPubMed
Amick BC, Gimeno D. Measuring work outcomes with a focus on health-related work productivity loss. In: Wittink H, Carr D, editors. Pain management: evidence, outcomes, and quality of life: a sourcebook. Amsterdam: Elsevier; 2008. p. 329–43.
Manea L, Gilbody S, McMillan D. A diagnostic meta-analysis of the patient health questionnaire-9 (PHQ-9) algorithm scoring method as a screen for depression. Gen Hosp Psychiatry. 2015;37(1):67–75. https://doi.org/10.1016/j.genhosppsych.2014.09.009. CrossRefPubMed
Dorland HF, Abma FI, Roelen CAM, Smink A, Feuerstein M, Amick BC, et al. The cognitive symptom checklist-work in cancer patients is related with work functioning, fatigue and depressive symptoms: a validation study. J Cancer Surviv. 2016;10(3):545–52. https://doi.org/10.1007/s11764-015-0500-9. CrossRefPubMed
Calvio L, Peugeot M, Bruns GL, Todd BL, Feuerstein M. Measures of cognitive function and work in occupationally active breast cancer survivors. JOEM. 2010;52(2):219–27. https://doi.org/10.1097/JOM.0b013e3181d0bef7. PubMedCrossRef
Twisk J. Applied longitudinal data analysis for epidemiology, a practical guide. New York: Cambridge University Press; 2003.
Dorland HF, Abma FI, Roelen CAM, Smink JG, Ranchor AV, Bültmann U. Factors influencing work functioning after cancer diagnosis: a focus group study with cancer survivors and occupational health professionals. Support Care Cancer. 2016;24(1):261–6. https://doi.org/10.1007/s00520-015-2764-z. CrossRefPubMed
- Fatigue and depressive symptoms improve but remain negatively related to work functioning over 18 months after return to work in cancer patients
H. F. Dorland
F. I. Abma
S. K. R. Van Zon
R. E. Stewart
B. C. Amick
A. V. Ranchor
C. A. M. Roelen
- Springer US